<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32548665</PMID><DateCompleted><Year>2021</Year><Month>06</Month><Day>07</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1559-1182</ISSN><JournalIssue CitedMedium="Internet"><Volume>57</Volume><Issue>8</Issue><PubDate><Year>2020</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Molecular neurobiology</Title><ISOAbbreviation>Mol Neurobiol</ISOAbbreviation></Journal><ArticleTitle>All-Trans Retinoic Acid Exerts Neuroprotective Effects in Amyotrophic Lateral Sclerosis-Like Tg (SOD1*G93A)1Gur Mice.</ArticleTitle><Pagination><StartPage>3603</StartPage><EndPage>3615</EndPage><MedlinePgn>3603-3615</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s12035-020-01973-8</ELocationID><Abstract><AbstractText>All-trans retinoic acid (ATRA), a ligand of retinoic acid receptors, could regulate various biological processes by activating retinoic acid signals. Recent studies suggested that ATRA displays multiple neuroprotective effects and thereby alleviates the disease progression in a variety of neurological diseases. Our previous studies found that the impaired retinoic acid signal decreased ALDH1A2, an essential synthetase of ATRA, in the spinal cord of ALS mice. Here, we evaluated the neuroprotective and neurorestorative effects of ATRA in a SOD1-G93A transgenic mice model of ALS. We administrated ATRA(3&#xa0;mg/kg) daily from the onset stage to the progression stage for 5&#xa0;weeks. Behavioral tests showed that ATRA improved the forelimb grip strength in ALS mice and may slow the disease progression, but not the body weight. ATRA could completely reverse the impaired retinoic acid receptor alpha (RAR&#x3b1;) signal in the spinal cord of ALS mice. This effect was accompanied by enhancing the degradation of misfolded proteins via the ubiquitin-proteasome system, regulating the oxidative stress, inhibiting the astrocyte activation, and promoting the neurotrophic signal recovery. Our findings are the first to indicate that the damaged retinoic acid signal is involved in the pathogenesis of ALS, and ATRA could induce the functional neuroprotection via repairing the damaged retinoic acid signal.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Zhu</LastName><ForeName>Yu</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, Affiliated People's Hospital of Nanchang University, Jiangxi Provincial People's Hospital, Nanchang, 330006, Jiangxi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, First Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Liu</LastName><ForeName>Yue</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Neurology, First Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Yang</LastName><ForeName>Fang</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Neurology, First Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Wenzhi</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Neurology, First Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Jianxian</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Neurology, Affiliated People's Hospital of Nanchang University, Jiangxi Provincial People's Hospital, Nanchang, 330006, Jiangxi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, First Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>He</LastName><ForeName>Pei</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Department of Neurology, Affiliated People's Hospital of Nanchang University, Jiangxi Provincial People's Hospital, Nanchang, 330006, Jiangxi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, First Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jiang</LastName><ForeName>Shishi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neurology, Affiliated People's Hospital of Nanchang University, Jiangxi Provincial People's Hospital, Nanchang, 330006, Jiangxi, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Neurology, First Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Menhua</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Neurology, First Affiliated Hospital of Nanchang University, Nanchang, 330006, Jiangxi, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Renshi</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0003-0313-3434</Identifier><AffiliationInfo><Affiliation>Department of Neurology, Affiliated People's Hospital of Nanchang University, Jiangxi Provincial People's Hospital, Nanchang, 330006, Jiangxi, China. xurenshi@ncu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>30560042, 81160161, 81360198</GrantID><Agency>National Natural Science Foundation of China</Agency><Country/></Grant><Grant><GrantID>GJJ13198, GJJ170021</GrantID><Agency>Education Department of Jiangxi Province</Agency><Country/></Grant><Grant><GrantID>20142BBG70062, 20192BAB205043, 20171BAB215022</GrantID><Agency>Jiangxi Provincial Department of Science and Technology</Agency><Country/></Grant><Grant><GrantID>Jiangxi Finance Elite Education Refers to [2015] 108</GrantID><Agency>Jiangxi Provincial Department of Science and Technology Gan Po Elite 555</Agency><Country/></Grant><Grant><GrantID>20181019</GrantID><Agency>Health and Family Planning Commission of Jiangxi province</Agency><Country/></Grant><Grant><GrantID>YC2016-B027, YC2015-S097</GrantID><Agency>Innovation Fund Designated for Graduate Students of Jiangxi Province</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Mol Neurobiol</MedlineTA><NlmUniqueID>8900963</NlmUniqueID><ISSNLinking>0893-7648</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D018696">Neuroprotective Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>5688UTC01R</RegistryNumber><NameOfSubstance UI="D014212">Tretinoin</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D013482">Superoxide Dismutase</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001253" MajorTopicYN="N">Astrocytes</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018450" MajorTopicYN="N">Disease Progression</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018696" MajorTopicYN="N">Neuroprotective Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013482" MajorTopicYN="N">Superoxide Dismutase</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014212" MajorTopicYN="N">Tretinoin</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">All-trans retinoic acid</Keyword><Keyword MajorTopicYN="N">Amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">Neuroprotection</Keyword><Keyword MajorTopicYN="N">Retinoic acid signal</Keyword><Keyword MajorTopicYN="N">Spinal cord</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>2</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>6</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>6</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32548665</ArticleId><ArticleId IdType="doi">10.1007/s12035-020-01973-8</ArticleId><ArticleId IdType="pii">10.1007/s12035-020-01973-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ludolph AC, Brettschneider J, Weishaupt JH (2012) Amyotrophic lateral sclerosis. Curr Opin Neurol 25:530&#x2013;535. https://doi.org/10.1097/WCO.0b013e328356d328</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/WCO.0b013e328356d328</ArticleId><ArticleId IdType="pubmed">22918486</ArticleId></ArticleIdList></Reference><Reference><Citation>Zarei S, Carr K, Reiley L, Diaz K, Guerra O, Altamirano PF, Pagani W, Lodin D et al (2015) A comprehensive review of amyotrophic lateral sclerosis. Surg Neurol Int 6:171. https://doi.org/10.4103/2152-7806.169561</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/2152-7806.169561</ArticleId><ArticleId IdType="pubmed">26629397</ArticleId><ArticleId IdType="pmc">4653353</ArticleId></ArticleIdList></Reference><Reference><Citation>Grad LI, Rouleau GA, Ravits J et al (2017) Clinical spectrum of amyotrophic lateral sclerosis (ALS). Cold Spring Harb Perspect Med 7(8):1&#x2013;16. https://doi.org/10.1101/cshperspect.a024117</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a024117</ArticleId></ArticleIdList></Reference><Reference><Citation>Hardiman O, Al-Chalabi A, Chio A et al (2017) Amyotrophic lateral sclerosis. Nat Rev Dis Primers 3:17071. https://doi.org/10.1038/nrdp.2017.85</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.85</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbeito AG, Mesci P, Boill&#xe9;e S (2010) Motor neuron-immune interactions: the vicious circle of ALS. J Neural Transm (Vienna) 117:981&#x2013;1000. https://doi.org/10.1007/s00702-010-0429-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00702-010-0429-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Ross CA, Poirier MA (2004) Protein aggregation and neurodegenerative disease. Nat Med 10:S10&#x2013;S17. https://doi.org/10.1038/nm1066</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm1066</ArticleId><ArticleId IdType="pubmed">15272267</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr&#xec; MT, D'Ambrosi N, Cozzolino M (2017) Pathways to mitochondrial dysfunction in ALS pathogenesis. Biochem Biophys Res Commun 483(4):1187&#x2013;1193. https://doi.org/10.1016/j.bbrc.2016.07.055</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.07.055</ArticleId><ArticleId IdType="pubmed">27416757</ArticleId></ArticleIdList></Reference><Reference><Citation>Parakh S, Spencer DM, Halloran MA, Soo KY, Atkin JD (2013) Redox regulation in amyotrophic lateral sclerosis. Oxidative Med Cell Longev 2013:408681&#x2013;408612. https://doi.org/10.1155/2013/408681</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2013/408681</ArticleId></ArticleIdList></Reference><Reference><Citation>D'Amico E, Factor-Litvak P, Santella RM et al (2013) Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis. Free Radic Biol Med 65:509&#x2013;527. https://doi.org/10.1016/j.freeradbiomed.2013.06.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2013.06.029</ArticleId><ArticleId IdType="pubmed">23797033</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghavami S, Shojaei S, Yeganeh B, Ande SR, Jangamreddy JR, Mehrpour M, Christoffersson J, Chaabane W et al (2014) Autophagy and apoptosis dysfunction in neurodegenerative disorders. Prog Neurobiol 112:24&#x2013;49. https://doi.org/10.1016/j.pneurobio.2013.10.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2013.10.004</ArticleId><ArticleId IdType="pubmed">24211851</ArticleId></ArticleIdList></Reference><Reference><Citation>Mic FA, Molotkov A, Benbrook DM, Duester G (2003) Retinoid activation of retinoic acid receptor but not retinoid X receptor is sufficient to rescue lethal defect in retinoic acid synthesis. Proc Natl Acad Sci U S A 100(12):7135&#x2013;7140. https://doi.org/10.1073/pnas.1231422100</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1231422100</ArticleId><ArticleId IdType="pubmed">12782789</ArticleId><ArticleId IdType="pmc">165842</ArticleId></ArticleIdList></Reference><Reference><Citation>Hall JA, Grainger JR, Spencer SP, Belkaid Y (2011) The role of retinoic acid in tolerance and immunity. Immunity 35:13&#x2013;22. https://doi.org/10.1016/j.immuni.2011.07.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2011.07.002</ArticleId><ArticleId IdType="pubmed">21777796</ArticleId><ArticleId IdType="pmc">3418663</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Gao X, Wang Q, Yang Y, Liu H, Zhang B, Li L (2017) Retinoic acid protects from experimental cerebral infarction by upregulating GAP-43 expression. Braz J Med Biol Res 50(4):e5561. https://doi.org/10.1590/1414-431X20175561</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/1414-431X20175561</ArticleId><ArticleId IdType="pubmed">28380213</ArticleId><ArticleId IdType="pmc">5423748</ArticleId></ArticleIdList></Reference><Reference><Citation>Sabbaghziarani F, Mortezaee K, Akbari M, kashani IR, Soleimani M, Moini A, Ataeinejad N, Zendedel A et al (2017) Retinoic acid-pretreated Wharton's jelly mesenchymal stem cells in combination with triiodothyronine improve expression of neurotrophic factors in the subventricular zone of the rat ischemic brain injury. Metab Brain Dis 32(1):185&#x2013;193. https://doi.org/10.1007/s11011-016-9897-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11011-016-9897-8</ArticleId><ArticleId IdType="pubmed">27549229</ArticleId></ArticleIdList></Reference><Reference><Citation>Nally JE, Clayton RA, Wakelam MJ et al (1994) Angiotensin II enhances responses to endothelin-1 in bovine bronchial smooth muscle. Pulm Pharmacol 7(6):409&#x2013;413. https://doi.org/10.1006/pulp.1994.1048</Citation><ArticleIdList><ArticleId IdType="doi">10.1006/pulp.1994.1048</ArticleId><ArticleId IdType="pubmed">7549229</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrirchian MH, Mohammadzadeh HN, Koohdani F et al (2014) The effect of vitamin a supplementation on disease progression, cytokine levels and gene expression in multiple sclerotic patients: study protocol for a randomized controlled trial. Acta Med Iran 52:94&#x2013;100</Citation><ArticleIdList><ArticleId IdType="pubmed">24659064</ArticleId></ArticleIdList></Reference><Reference><Citation>Racke MK, Burnett D, Pak SH et al (1995) Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J Immunol 154:450&#x2013;458. https://doi.org/10.1080/15321819508013572</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/15321819508013572</ArticleId><ArticleId IdType="pubmed">7527821</ArticleId></ArticleIdList></Reference><Reference><Citation>Takamura R, Watamura N, Nikkuni M et al (2017) All-trans retinoic acid improved impaired proliferation of neural stem cells and suppressed microglial activation in the hippocampus in an Alzheimer&#x2019;s mouse model. J Neurosci Res 95:897&#x2013;906. https://doi.org/10.1002/jnr.23843</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jnr.23843</ArticleId><ArticleId IdType="pubmed">27448243</ArticleId></ArticleIdList></Reference><Reference><Citation>Altucci L, Gronemeyer H (2001) The promise of retinoids to fight against cancer. Nat Rev Cancer 1:181&#x2013;193. https://doi.org/10.1038/35106036</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/35106036</ArticleId><ArticleId IdType="pubmed">11902573</ArticleId></ArticleIdList></Reference><Reference><Citation>Anguiano J, Garner TP, Mahalingam M, Das BC, Gavathiotis E, Cuervo AM (2013) Chemical modulation of chaperone-mediated autophagy by retinoic acid derivatives. Nat Chem Biol 9:374&#x2013;382. https://doi.org/10.1038/nchembio.1230</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.1230</ArticleId><ArticleId IdType="pubmed">23584676</ArticleId><ArticleId IdType="pmc">3661710</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcoran JP, So PL, Maden M (2004) Disruption of the retinoid signalling pathway causes a deposition of amyloid beta in the adult rat brain. Eur J Neurosci 20:896&#x2013;902. https://doi.org/10.1111/j.1460-9568.2004.03563.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1460-9568.2004.03563.x</ArticleId><ArticleId IdType="pubmed">15305858</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Huang P, Wu C, Liang H, Li Y, Zhu L, Lu Y, Tang C et al (2018) Preliminary observation about alteration of proteins and their potential functions in spinal cord of SOD1 G93A transgenic mice. Int J Biol Sci 14:1306&#x2013;1320. https://doi.org/10.7150/ijbs.26829</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.26829</ArticleId><ArticleId IdType="pubmed">30123078</ArticleId><ArticleId IdType="pmc">6097476</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang H, Wu C, Deng Y, Zhu L, Zhang J, Gan W, Tang C, Xu R (2017) Aldehyde dehydrogenases 1A2 expression and distribution are potentially associated with neuron death in spinal cord of Tg (SOD1*G93A)1Gur mice. Int J Biol Sci 13:574&#x2013;587. https://doi.org/10.7150/ijbs.19150</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.19150</ArticleId><ArticleId IdType="pubmed">28539831</ArticleId><ArticleId IdType="pmc">5441175</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Q, Zhu L, Qiu W, Liu Y, Yang F, Chen W, Xu R (2020) Nicotinamide riboside enhances mitochondrial proteostasis and adult neurogenesis through activation of mitochondrial unfolded protein response signaling in the brain of ALS SOD1 mice. Int J Biol Sci 16:284&#x2013;297. https://doi.org/10.7150/ijbs.38487</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.38487</ArticleId><ArticleId IdType="pubmed">31929756</ArticleId><ArticleId IdType="pmc">6949147</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Guo Y, Wang X, Yu X, Duan W, Hong K, Wang J, Han H et al (2015) Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1 G93A mouse model. Neuroscience 298:12&#x2013;25. https://doi.org/10.1016/j.neuroscience.2015.03.061</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuroscience.2015.03.061</ArticleId><ArticleId IdType="pubmed">25841320</ArticleId></ArticleIdList></Reference><Reference><Citation>Oliv&#xe1;n S, Calvo AC, Rando A et al (2015) Comparative study of behavioural tests in the SOD1G93A mouse model of amyotrophic lateral sclerosis. Exp Anim 64(2):147&#x2013;153. https://doi.org/10.1538/expanim.14-0077</Citation><ArticleIdList><ArticleId IdType="doi">10.1538/expanim.14-0077</ArticleId><ArticleId IdType="pubmed">25736480</ArticleId></ArticleIdList></Reference><Reference><Citation>Weydt P, Hong SY, Kliot M et al (2003) Assessing disease onset and progression in the SOD1 mouse model of ALS. Neuroreport 14:1051&#x2013;1054. https://doi.org/10.1097/01.wnr.0000073685.00308.89</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/01.wnr.0000073685.00308.89</ArticleId><ArticleId IdType="pubmed">12802201</ArticleId></ArticleIdList></Reference><Reference><Citation>Knippenberg S, Thau N, Dengler R, Petri S (2010) Significance of behavioural tests in a transgenic mouse model of amyotrophic lateral sclerosis (ALS). Behav Brain Res 213(1):82&#x2013;87. https://doi.org/10.1016/j.bbr.2010.04.042</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbr.2010.04.042</ArticleId><ArticleId IdType="pubmed">20450936</ArticleId></ArticleIdList></Reference><Reference><Citation>Scott S, Kranz JE, Cole J, Lincecum JM, Thompson K, Kelly N, Bostrom A, Theodoss J et al (2008) Design, power, and interpretation of studies in the standard murine model of ALS. Amyotroph Lateral Scler 9:4&#x2013;15. https://doi.org/10.1080/17482960701856300</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960701856300</ArticleId><ArticleId IdType="pubmed">18273714</ArticleId></ArticleIdList></Reference><Reference><Citation>Lincecum JM, Vieira FG, Wang MZ, Thompson K, de Zutter GS, Kidd J, Moreno A, Sanchez R et al (2010) From transcriptome analysis to therapeutic anti-CD40L treatment in the SOD1 model of amyotrophic lateral sclerosis. Nat Genet 42:392&#x2013;399. https://doi.org/10.1038/ng.557</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng.557</ArticleId><ArticleId IdType="pubmed">20348957</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludolph AC, Bendotti C, Blaugrund E, Chio A, Greensmith L, Loeffler JP, Mead R, Niessen HG et al (2010) Guidelines for preclinical animal research in ALS/MND: A consensus meeting. Amyotroph Lateral Scler 11:38&#x2013;45. https://doi.org/10.3109/17482960903545334</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960903545334</ArticleId><ArticleId IdType="pubmed">20184514</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang J, Liang H, Zhu L, Gan W, Tang C, Li J, Xu R (2018) Expression and distribution of Arylsulfatase B are closely associated with neuron death in SOD1 G93A transgenic mice. Mol Neurobiol 55:1323&#x2013;1337. https://doi.org/10.1007/s12035-017-0406-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-017-0406-9</ArticleId><ArticleId IdType="pubmed">28124772</ArticleId></ArticleIdList></Reference><Reference><Citation>Francardo V, Recchia A, Popovic N, Andersson D, Nissbrandt H, Cenci MA (2011) Impact of the lesion procedure on the profiles of motor impairment and molecular responsiveness to L-DOPA in the 6-hydroxydopamine mouse model of Parkinson&#x2019;s disease. Neurobiol Dis 42:327&#x2013;340. https://doi.org/10.1016/j.nbd.2011.01.024</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.nbd.2011.01.024</ArticleId><ArticleId IdType="pubmed">21310234</ArticleId></ArticleIdList></Reference><Reference><Citation>Maden M (2006) Retinoids and spinal cord development. J Neurobiol 66:726&#x2013;738. https://doi.org/10.1002/neu.20248</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/neu.20248</ArticleId><ArticleId IdType="pubmed">16688770</ArticleId></ArticleIdList></Reference><Reference><Citation>Ji SJ, Zhuang BQ, Falco C, Schneider A, Schuster-Gossler K, Gossler A, Sockanathan S (2006) Mesodermal and neuronal retinoids regulate the induction and maintenance of limb innervating spinal motor neurons. Dev Biol 297:249&#x2013;261. https://doi.org/10.1016/j.ydbio.2006.05.015</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ydbio.2006.05.015</ArticleId><ArticleId IdType="pubmed">16781703</ArticleId></ArticleIdList></Reference><Reference><Citation>Maden M (2007) Retinoic acid in the development, regeneration and maintenance of the nervous system. Nat Rev Neurosci 8:755&#x2013;765. https://doi.org/10.1038/nrn2212</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn2212</ArticleId><ArticleId IdType="pubmed">17882253</ArticleId></ArticleIdList></Reference><Reference><Citation>Rosenbohm A, Nagel G, Peter RS, Brehme T, Koenig W, Dupuis L, Rothenbacher D, Ludolph AC et al (2018) Association of serum retinol-binding protein 4 concentration with risk for and prognosis of amyotrophic lateral sclerosis. JAMA Neurol 75(5):600&#x2013;607. https://doi.org/10.1001/jamaneurol.2017.5129</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2017.5129</ArticleId><ArticleId IdType="pubmed">29482216</ArticleId><ArticleId IdType="pmc">5885207</ArticleId></ArticleIdList></Reference><Reference><Citation>Jokic N, Ling YY, Ward RE, Michael-Titus AT, Priestley JV, Malaspina A (2007) Retinoid receptors in chronic degeneration of the spinal cord: observations in a rat model of amyotrophic lateral sclerosis. J Neurochem 103:1821&#x2013;1833. https://doi.org/10.1111/j.1471-4159.2007.04893.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2007.04893.x</ArticleId><ArticleId IdType="pubmed">17956549</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J, Lu Y, Liang H, Tang C, Zhu L, Zhang J, Xu R (2016) Changes in the expression of FUS/TLS in spinal cords of SOD1 G93A transgenic mice and correlation with motor-neuron degeneration. Int J Biol Sci 12:1181&#x2013;1190. https://doi.org/10.7150/ijbs.16158</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.16158</ArticleId><ArticleId IdType="pubmed">27766033</ArticleId><ArticleId IdType="pmc">5069440</ArticleId></ArticleIdList></Reference><Reference><Citation>Lu Y, Tang C, Zhu L, Li J, Liang H, Zhang J, Xu R (2016) The overexpression of TDP-43 protein in the neuron and oligodendrocyte cells causes the progressive motor neuron degeneration in the SOD1 G93A transgenic mouse model of amyotrophic lateral sclerosis. Int J Biol Sci 12:1140&#x2013;1149. https://doi.org/10.7150/ijbs.15938</Citation><ArticleIdList><ArticleId IdType="doi">10.7150/ijbs.15938</ArticleId><ArticleId IdType="pubmed">27570488</ArticleId><ArticleId IdType="pmc">4997058</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra A, Maheshwari M, Chhangani D et al (2013) E6-AP association promotes SOD1 aggresomes degradation and suppresses toxicity. Neurobiol Aging 34:1310.e11&#x2013;1310.e23. https://doi.org/10.1016/j.neurobiolaging.2012.08.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.08.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarafdar A, Pula G (2018) The role of NADPH oxidases and oxidative stress in neurodegenerative disorders. Int J Mol Sci 19(12):E3824. https://doi.org/10.3390/ijms19123824</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijms19123824</ArticleId><ArticleId IdType="pubmed">30513656</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopert P, Patel M (2014) Nicotinamide nucleotide transhydrogenase (Nnt) links the substrate requirement in brain mitochondria for hydrogen peroxide removal to the thioredoxin/peroxiredoxin (Trx/Prx) system. J Biol Chem 289:15611&#x2013;15620. https://doi.org/10.1074/jbc.M113.533653</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M113.533653</ArticleId><ArticleId IdType="pubmed">24722990</ArticleId><ArticleId IdType="pmc">4140916</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K, Komine O (2018) The multi-dimensional roles of astrocytes in ALS. Neurosci Res 126:31&#x2013;38. https://doi.org/10.1016/j.neures.2017.09.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neures.2017.09.011</ArticleId><ArticleId IdType="pubmed">29054467</ArticleId></ArticleIdList></Reference><Reference><Citation>Pehar M, Harlan B, Killoy KM, Vargas MR (2017) Role and therapeutic potential of astrocytes in amyotrophic lateral sclerosis. Curr Pharm Des 23:5010&#x2013;5021. https://doi.org/10.2174/1381612823666170622095802</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612823666170622095802</ArticleId><ArticleId IdType="pubmed">28641533</ArticleId><ArticleId IdType="pmc">5740017</ArticleId></ArticleIdList></Reference><Reference><Citation>Dawbarn D, Allen SJ (2003) Neurotrophins and neurodegeneration. Neuropathol Appl Neurobiol 29:211&#x2013;230. https://doi.org/10.1046/j.1365-2990.2003.00487.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1365-2990.2003.00487.x</ArticleId><ArticleId IdType="pubmed">12787319</ArticleId></ArticleIdList></Reference><Reference><Citation>Anand P, Parrett A, Martin J, Zeman S, Foley P, Swash M, Leigh PN, Cedarbaum JM et al (1995) Regional changes of ciliary neurotrophic factor and nerve growth factor levels in post mortem spinal cord and cerebral cortex from patients with motor disease. Nat Med 1:168&#x2013;172. https://doi.org/10.1038/nm0295-168</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm0295-168</ArticleId><ArticleId IdType="pubmed">7585015</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang Y, Yamamoto M, Kobayashi Y et al (2010) Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis. Ann Neurol 57(2):236&#x2013;251. https://doi.org/10.1002/ana.20379</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.20379</ArticleId></ArticleIdList></Reference><Reference><Citation>Kolarcik C, Bowser R (2011) Retinoid signaling alterations in amyotrophic lateral sclerosis. Am J Neurodegener Dis 1(1):130&#x2013;145</Citation></Reference><Reference><Citation>Riancho J, Ruiz-Soto M, Berciano MT, Berciano J, Lafarga M (2015) Neuroprotective effect of bexarotene in the SOD1G93A mouse model of amyotrophic lateral sclerosis. Front Cell Neurosci 9:250. https://doi.org/10.3389/fncel.2015.00250</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2015.00250</ArticleId><ArticleId IdType="pubmed">26190974</ArticleId><ArticleId IdType="pmc">4486838</ArticleId></ArticleIdList></Reference><Reference><Citation>Fedders R, Muenzner M, Weber P, Sommerfeld M, Knauer M, Kedziora S, Kast N, Heidenreich S et al (2018) Liver-secreted RBP4 does not impair glucose homeostasis in mice. J Biol Chem 293:15269&#x2013;15276. https://doi.org/10.1074/jbc.RA118.004294</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.RA118.004294</ArticleId><ArticleId IdType="pubmed">30126844</ArticleId><ArticleId IdType="pmc">6166712</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai W, Wang J, Hu M, Chen X, Lu Z, Bellanti JA, Zheng SG (2019) All trans-retinoic acid protects against acute ischemic stroke by modulating neutrophil functions through STAT1 signaling. J Neuroinflammation 16:175. https://doi.org/10.1186/s12974-019-1557-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12974-019-1557-6</ArticleId><ArticleId IdType="pubmed">31472680</ArticleId><ArticleId IdType="pmc">6717357</ArticleId></ArticleIdList></Reference><Reference><Citation>Leid M, Kastner P, Durand B et al (1993) Retinoic acid signal transduction pathways. Ann N Y Acad Sci 684:19&#x2013;34. https://doi.org/10.1111/j.1749-6632.1993.tb32268.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1749-6632.1993.tb32268.x</ArticleId><ArticleId IdType="pubmed">8317828</ArticleId></ArticleIdList></Reference><Reference><Citation>Allenby G, Bocquel MT, Saunders M, Kazmer S, Speck J, Rosenberger M, Lovey A, Kastner P et al (1993) Retinoic acid receptors and retinoid X receptors: interactions with endogenous retinoic acids. Proc Natl Acad Sci U S A 90(1):30&#x2013;34. https://doi.org/10.1073/pnas.90.1.30</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.90.1.30</ArticleId><ArticleId IdType="pubmed">8380496</ArticleId><ArticleId IdType="pmc">45593</ArticleId></ArticleIdList></Reference><Reference><Citation>Germain P, Chambon P, Eichele G, Evans RM, Lazar MA, Leid M, de Lera AR, Lotan R et al (2006) International union of pharmacology LX retinoic acid receptors. Pharmacol Rev 58(4):712&#x2013;725. https://doi.org/10.1124/pr.58.4.4</Citation><ArticleIdList><ArticleId IdType="doi">10.1124/pr.58.4.4</ArticleId><ArticleId IdType="pubmed">17132850</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcoran JP, So PL, Maden M (2002) Absence of retinoids can induce motor neuron disease in the adult rat and a retinoid defect is present in motor neuron disease patients. J Cell Sci 115:4735&#x2013;4741. https://doi.org/10.1242/jcs.00169</Citation><ArticleIdList><ArticleId IdType="doi">10.1242/jcs.00169</ArticleId><ArticleId IdType="pubmed">12432062</ArticleId></ArticleIdList></Reference><Reference><Citation>Lane MA, Bailey SJ (2005) Role of retinoid signalling in the adult brain. Prog Neurobiol 75:275&#x2013;293. https://doi.org/10.1016/j.pneurobio.2005.03.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pneurobio.2005.03.002</ArticleId><ArticleId IdType="pubmed">15882777</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurtishi A, Rosen B, Patil KS, Alves GW, M&#xf8;ller SG (2018) Cellular proteostasis in neurodegeneration. Mol Neurobiol 56(5):3676&#x2013;3689. https://doi.org/10.1007/s12035-018-1334-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12035-018-1334-z</ArticleId><ArticleId IdType="pubmed">30182337</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra A, Maheshwari M, Chhangani D, Fujimori-Tonou N, Endo F, Joshi AP, Jana NR, Yamanaka K (2013) E6-AP association promotes SOD1 aggresomes degradation and suppresses toxicity. Neurobiol Aging 34(1310):e11&#x2013;e23. https://doi.org/10.1016/j.neurobiolaging.2012.08.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.08.016</ArticleId></ArticleIdList></Reference><Reference><Citation>Bozzo F, Mirra A, Carr&#xec; MT (2017) Oxidative stress and mitochondrial damage in the pathogenesis of ALS: New perspectives. Neurosci Lett 636:3&#x2013;8. https://doi.org/10.1016/j.neulet.2016.04.065</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2016.04.065</ArticleId><ArticleId IdType="pubmed">27150074</ArticleId></ArticleIdList></Reference><Reference><Citation>Chico L, Modena M, Lo Gerfo A, Ricci G, Caldarazzo Ienco E, Ryskalin L, Fornai F, Siciliano G (2017) Cross-talk between pathogenic mechanisms in neurodegeneration: the role of oxidative stress in amyotrophic lateral sclerosis [J]. Arch Ital Biol 155(4):131&#x2013;141. https://doi.org/10.12871/00039829201744</Citation><ArticleIdList><ArticleId IdType="doi">10.12871/00039829201744</ArticleId><ArticleId IdType="pubmed">29405030</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothstein JD (2017) Edaravone: a new drug approved for ALS. Cell 171(4):725. https://doi.org/10.1016/j.cell.2017.10.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2017.10.011</ArticleId><ArticleId IdType="pubmed">29100067</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhandari R, Kuhad A, Kuhad A (2018) Edaravone: a new hope for deadly amyotrophic lateral sclerosis. Drugs Today (Barc) 54(6):349&#x2013;360. https://doi.org/10.1358/dot.2018.54.6.2828189</Citation><ArticleIdList><ArticleId IdType="doi">10.1358/dot.2018.54.6.2828189</ArticleId></ArticleIdList></Reference><Reference><Citation>Busanello ENB, Figueira TR, Marques AC, Navarro CDC, Oliveira HCF, Vercesi AE (2018) Facilitation of Ca2+&#x2212;induced opening of the mitochondrial permeability transition pore either by nicotinamide nucleotide transhydrogenase deficiency or statins treatment. Cell Biol Int 42(6):742&#x2013;746. https://doi.org/10.1002/cbin.10949</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbin.10949</ArticleId><ArticleId IdType="pubmed">29424467</ArticleId></ArticleIdList></Reference><Reference><Citation>Calabrese V, Guagliano E, Sapienza M et al (2006) Redox regulation of cellular stress response in neurodegenerative disorders. Ital J Biochem 55(3&#x2013;4):263&#x2013;282</Citation><ArticleIdList><ArticleId IdType="pubmed">17274531</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo X, Namekata K, Kimura A, Harada C, Harada T (2017) ASK1 in neurodegeneration. Adv Biol Regul 66:63&#x2013;71. https://doi.org/10.1016/j.jbior.2017.08.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jbior.2017.08.003</ArticleId><ArticleId IdType="pubmed">28882588</ArticleId></ArticleIdList></Reference><Reference><Citation>Conrad M, Schick J, Angeli JP (2013) Glutathione and thioredoxin dependent systems in neurodegenerative disease: what can be learned from reverse genetics in mice. Neurochem Int 62(5):738&#x2013;749. https://doi.org/10.1016/j.neuint.2013.01.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuint.2013.01.010</ArticleId><ArticleId IdType="pubmed">23333338</ArticleId></ArticleIdList></Reference><Reference><Citation>Boill&#xe9;e S, Vande VC, Cleveland DW (2006) ALS: a disease of motor neurons and their nonneuronal neighbors. Neuron 52(1):39&#x2013;59. https://doi.org/10.1016/j.neuron.2006.09.018</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2006.09.018</ArticleId><ArticleId IdType="pubmed">17015226</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J, Hyeon SJ, Im H et al (2016) Astrocytes and microglia as non-cell autonomous players in the pathogenesis of ALS. Exp Neurobiol 25(5):233&#x2013;240. https://doi.org/10.5607/en.2016.25.5.233</Citation><ArticleIdList><ArticleId IdType="doi">10.5607/en.2016.25.5.233</ArticleId><ArticleId IdType="pubmed">27790057</ArticleId><ArticleId IdType="pmc">5081469</ArticleId></ArticleIdList></Reference><Reference><Citation>Finsterwald C, Magistretti PJ, Lengacher S (2015) Astrocytes: New targets for the treatment of neurodegenerative diseases. Curr Pharm Des 21(25):3570&#x2013;3581. https://doi.org/10.2174/1381612821666150710144502</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612821666150710144502</ArticleId><ArticleId IdType="pubmed">26166612</ArticleId></ArticleIdList></Reference><Reference><Citation>Allen SJ, Watson JJ, Shoemark DK, Barua NU, Patel NK (2013) GDNF, NGF and BDNF as therapeutic options for neurodegeneration. Pharmacol Ther 138:155&#x2013;175. https://doi.org/10.1016/j.pharmthera.2013.01.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pharmthera.2013.01.004</ArticleId><ArticleId IdType="pubmed">23348013</ArticleId></ArticleIdList></Reference><Reference><Citation>Sampaio TB, Savall AS, Gutierrez M et al (2017) Neurotrophic factors in Alzheimer's and Parkinson's diseases: implications for pathogenesis and therapy. Neural Regen Res 12:549&#x2013;557. https://doi.org/10.4103/1673-5374.205084</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1673-5374.205084</ArticleId><ArticleId IdType="pubmed">28553325</ArticleId><ArticleId IdType="pmc">5436343</ArticleId></ArticleIdList></Reference><Reference><Citation>Dechant G, Barde YA (2002) The neurotrophin receptor p75NTR: novel functions and implications for diseases of the nervous system. Nat Neurosci 5(11):1131&#x2013;1136. https://doi.org/10.1038/nn1102-1131</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1102-1131</ArticleId><ArticleId IdType="pubmed">12404007</ArticleId></ArticleIdList></Reference><Reference><Citation>Shu YH, Lu XM, Wei JX et al (2015) Update on the role of p75NTR in neurological disorders: A novel therapeutic target. Biomed Pharmacother 76:17&#x2013;23. https://doi.org/10.1016/j.biopha.2015.10.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biopha.2015.10.010</ArticleId><ArticleId IdType="pubmed">26653545</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee R, Kermani P, Teng KK et al (2002) Regulation of cell survival by secreted proneurotrophins. Science 294:1945&#x2013;1948. https://doi.org/10.1126/science.1065057</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1065057</ArticleId></ArticleIdList></Reference><Reference><Citation>Hempstead BL (2002) The many faces of p75NTR. Curr Opin Neurobiol 12:260&#x2013;267. https://doi.org/10.1016/s0959-4388(02)00321-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0959-4388(02)00321-5</ArticleId><ArticleId IdType="pubmed">12049931</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>